• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Bart L Scott, Marcelo C Pasquini, +17 authors Mitchell E Horwitz
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2017 (First Publication: 13 February 2017)
  • Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with reduced-intensityContinue Reading
  • Shaji K Kumar, Jesus G Berdeja, +16 authors Paul G Richardson
  • Medicine
  • The Lancet. Oncology
  • 2014 (First Publication: 1 December 2014)
  • BACKGROUND The combination of bortezomib, lenalidomide, and dexamethasone is a highly effective therapy for newly diagnosed multiple myeloma. Ixazomib is an investigational, oral, proteasomeContinue Reading
  • Vikas Gupta, Adriana K Malone, +34 authors Wael Saber
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2014
  • We evaluated outcomes and associated prognostic factors in 233 patients undergoing allogeneic hematopoietic cell transplantation (HCT) for primary myelofibrosis (MF) using reduced-intensityContinue Reading
  • Asad Bashey, Mei-Jie Zhang, +21 authors Mary Eapen
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2017 (First Publication: 23 June 2017)
  • Purpose T-cell-replete HLA-haploidentical donor hematopoietic transplantation using post-transplant cyclophosphamide was originally described using bone marrow (BM). With increasing use of mobilizedContinue Reading
  • Michael Sweet, Aaron Cumpston, Frank H. Briggs, Michael Craig, Mehdi Hamadani
  • Medicine
  • American journal of infection control
  • 2012 (First Publication: 1 December 2012)
  • BACKGROUND A major risk factor for the development of bloodstream infection is the presence of a central venous catheter (CVC), especially in immunocompromised patients. CVC hub contamination is aContinue Reading
  • Mehdi Hamadani, Craig C. Hofmeister, +9 authors Steven M. Devine
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2008 (First Publication: 1 July 2008)
  • Infliximab, a chimeric monoclonal antibody (mAb) against tumor necrosis factor (TNF)-alpha, has shown activity against steroid refractory acute graft-versus-host disease (aGVHD). We conducted aContinue Reading